Home / David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

Dec. 18, 2018

Many years ago when I first got into diabetes care there was constant pushback on the idea of a pharmacist managing diabetes patients. The idea that a pharmacist could actually do pump trainings was unheard of. I thought we Pharmacists would be a natural choice because of our drug knowledge, …

Read More »

Dec. 15, 2018

As we move into 2019 we may find that our patients are eligible for more technology and less expensive medications. Over the past few days I have been receiving ads on my Facebook page for the Dexcom 5 and 6 and Medicare coverage. Since my wife has been using mealtime …

Read More »

Dec. 13, 2018

This past week I was in our corporate offices and one of our District Managers came up to me and said he had developed type 1 diabetes. Although he is 42 years old, his physician had told him that his pancreas had quit working. His first indication was a loss …

Read More »

Dec. 8, 2018

It has always been thought that if you use marijuana, you will get the munchies, and we had a whole generation of pot users who just couldn’t get enough to eat. Back in the 70’s and 80’s, we were just beginning to be concerned with type 2 diabetes care and …

Read More »

Dec. 4, 2018

Alex Trebek has been hosting Jeopardy for the last 34 years. Can you imagine how many times a contestant has blurted out the phrase, “I’ll take medicine for 400 dollars”? In fact, matching a topic to a dollar amount is in much the same way a part of our culture …

Read More »

Dec. 1, 2018

For the last two years, my wife has been controlling her diabetes with long-acting insulin, a GLP-1 analog, and an SGLT-2 Inhibitor. After she was diagnosed two and a half years ago, she lost over 80 lbs and her A1c went from 13.7 to 7.2. Over the past four months, …

Read More »

Nov. 27, 2018

Last week, I got a new update of software for my Stages power meter. The Stages is a device that is milled into the left crank arm (what the pedal is screwed into) of my bike. This device measures the power (as wattage) that I create when I am on …

Read More »

Nov. 24, 2018

Over the last 25 years, we have been looking for add-on therapies to help our type 1 patients control their glucose without increasing the risk of hypoglycemia. As we have gotten better insulins and monitoring devices, there has been an intensification of control and that often leads to greater changes …

Read More »

Nov. 20, 2018

Although monogenic disorders of the beta cell account for only 1–2% of all diabetes, they are bound to show up sometime in your practice. They are discrete disorders that are a significant cause of diabetes in their own right. This week, in our Clinical Text, we begin a discussion of …

Read More »

Nov. 17, 2018

My wife sometimes fills in as a substitute teacher for the public school system, working with grade-school students. We often talk about the behavior of the kids and how she often feels more like a babysitter than a teacher because of behavior of many of the kids in the class. …

Read More »